Janssen-Cilag Polska Sp. z o.o. secures contract for Pharmaceutical products - Successive delivery of drugs used in the treatment of pulmonary fibrosis and lung cancer severe asthma multidrug-resistant tuberculosis atopic dermatitis and chronic spontaneous urticaria available under drug programs to the Provincial Complex of Health Care Facilities Center for the Treatment of Pulmonary Diseases and Rehabilitation in Lodz ul Okolna 181

Poland, May 21 -- Poland based Janssen-Cilag Polska Sp. z o.o. has secured contract from Krajowa Izba Odwolawcza for Pharmaceutical products - Successive delivery of drugs used in the treatment of pulmonary fibrosis and lung cancer severe asthma multidrug-resistant tuberculosis atopic dermatitis and chronic spontaneous urticaria available under drug programs to the Provincial Complex of Health Care Facilities Center for the Treatment of Pulmonary Diseases and Rehabilitation in Lodz ul Okolna 181 . The value of the contract is worth 74569896.0 PLN .

Published by HT Digital Content Services with permission from Pivotal Sources....